CIK 0001894525 · <br>Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851099700
- Phone
- 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- DEFM14C Other DEFM14C
- PREM14C Other PREM14C
- NT 10-Q Other NT 10-Q
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- NT 10-K Other NT 10-K
- CERT Other Certification
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- FWP Offering Free Writing Prospectus
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 1 of 2 · 23 filings